Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bridgitte Shen Lee

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Annals of Medicine|December 28, 2022
Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialistsJohn Sheppard, Bridgitte Shen Lee, Laura M Periman
Frontiers in Medicine|February 9, 2026
Impact of lotilaner ophthalmic solution 0.25% on disease severity in patients with <i>Demodex</i> blepharitis and meibomian gland diseaseBridgitte Shen Lee, Elizabeth Yeu, Kavita Dhamdhere, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 28, 2022
Open-Label Extension Study Comparing Latanoprost 0.005% Without vs With Benzalkonium Chloride in Open-Angle Glaucoma or Ocular HypertensionBridgitte Shen Lee, Ranjan Malhotra, Kenneth Sall, et al.
Ophthalmology and Therapy|May 24, 2022
Selective Pharmacologic Therapies for Dry Eye Disease Treatment: Efficacy, Tolerability, and Safety Data Review from Preclinical Studies and Pivotal TrialsBridgitte Shen Lee, Melissa Toyos, Paul Karpecki, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 6, 2020
Managing Dry Eye Disease and Facilitating Realistic Patient Expectations: A Review and Appraisal of Current TherapiesBridgitte Shen Lee, Alan G Kabat, Jason Bacharach, et al.
Clinical Ophthalmology (Auckland, N.Z.)|September 17, 2021
The Relationship Between Dry Eye Disease and Digital Screen UseZaina Al-Mohtaseb, Scott Schachter, Bridgitte Shen Lee, et al.
Eye & Contact Lens|March 17, 2022
Noninferiority Study Comparing Latanoprost 0.005% Without Versus With Benzalkonium Chloride in Open-Angle Glaucoma or Ocular HypertensionDavid Wirta, Ranjan Malhotra, James Peace, et al.
Clinical Ophthalmology (Auckland, N.Z.)|August 6, 2025
Early Adoption and Utilization of Perfluorohexyloctane for Dry Eye Disease in the United StatesBridgitte Shen Lee, Lia Pizzicato, Elizabeth Langford, et al.
Clinical Ophthalmology (Auckland, N.Z.)|March 25, 2026
Effects of Lotilaner Ophthalmic Solution, 0.25% on <i>Demodex</i> Blepharitis Patients with Meibomian Gland DiseasePreeya K Gupta, Ian Benjamin Gaddie, Mitchell C Shultz, et al.
Clinical Optometry|April 6, 2026
An Observational, Multicenter, Parallel-Cohort Study Evaluating the Association of Clinical Manifestations and Patient-Reported Outcomes in Patients with <i>Demodex</i> BlepharitisBridgitte Shen Lee, Nicole Fram, Ruth Lapid-Gortzak, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Annals of Medicine|December 28, 2022
Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialistsJohn Sheppard, Bridgitte Shen Lee, Laura M Periman
Frontiers in Medicine|February 9, 2026
Impact of lotilaner ophthalmic solution 0.25% on disease severity in patients with <i>Demodex</i> blepharitis and meibomian gland diseaseBridgitte Shen Lee, Elizabeth Yeu, Kavita Dhamdhere, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 28, 2022
Open-Label Extension Study Comparing Latanoprost 0.005% Without vs With Benzalkonium Chloride in Open-Angle Glaucoma or Ocular HypertensionBridgitte Shen Lee, Ranjan Malhotra, Kenneth Sall, et al.
Ophthalmology and Therapy|May 24, 2022
Selective Pharmacologic Therapies for Dry Eye Disease Treatment: Efficacy, Tolerability, and Safety Data Review from Preclinical Studies and Pivotal TrialsBridgitte Shen Lee, Melissa Toyos, Paul Karpecki, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 6, 2020
Managing Dry Eye Disease and Facilitating Realistic Patient Expectations: A Review and Appraisal of Current TherapiesBridgitte Shen Lee, Alan G Kabat, Jason Bacharach, et al.
Clinical Ophthalmology (Auckland, N.Z.)|September 17, 2021
The Relationship Between Dry Eye Disease and Digital Screen UseZaina Al-Mohtaseb, Scott Schachter, Bridgitte Shen Lee, et al.
Eye & Contact Lens|March 17, 2022
Noninferiority Study Comparing Latanoprost 0.005% Without Versus With Benzalkonium Chloride in Open-Angle Glaucoma or Ocular HypertensionDavid Wirta, Ranjan Malhotra, James Peace, et al.
Clinical Ophthalmology (Auckland, N.Z.)|August 6, 2025
Early Adoption and Utilization of Perfluorohexyloctane for Dry Eye Disease in the United StatesBridgitte Shen Lee, Lia Pizzicato, Elizabeth Langford, et al.
Clinical Ophthalmology (Auckland, N.Z.)|March 25, 2026
Effects of Lotilaner Ophthalmic Solution, 0.25% on <i>Demodex</i> Blepharitis Patients with Meibomian Gland DiseasePreeya K Gupta, Ian Benjamin Gaddie, Mitchell C Shultz, et al.
Clinical Optometry|April 6, 2026
An Observational, Multicenter, Parallel-Cohort Study Evaluating the Association of Clinical Manifestations and Patient-Reported Outcomes in Patients with <i>Demodex</i> BlepharitisBridgitte Shen Lee, Nicole Fram, Ruth Lapid-Gortzak, et al.
Pageof 2